Cargando…

Assessment of a Computational Approach to Predict Drug Resistance Mutations for HIV, HBV and SARS-CoV-2

Viral resistance is a worldwide problem mitigating the effectiveness of antiviral drugs. Mutations in the drug-targeting proteins are the primary mechanism for the emergence of drug resistance. It is essential to identify the drug resistance mutations to elucidate the mechanism of resistance and to...

Descripción completa

Detalles Bibliográficos
Autores principales:	Patel, Dharmeshkumar, Ono, Suzane K., Bassit, Leda, Verma, Kiran, Amblard, Franck, Schinazi, Raymond F.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457688/ https://www.ncbi.nlm.nih.gov/pubmed/36080181 http://dx.doi.org/10.3390/molecules27175413

Ejemplares similares

Synthesis of 4′-Substituted-2′-Deoxy-2′-α-Fluoro Nucleoside Analogs as Potential Antiviral Agents
por: Kasthuri, Mahesh, et al.
Publicado: (2020)

Comparison of anti-SARS-CoV-2 activity and intracellular metabolism of remdesivir and its parent nucleoside
por: Tao, Sijia, et al.
Publicado: (2021)

Approaches to hepatitis C treatment and cure using NS5A inhibitors
por: Kohler, James J, et al.
Publicado: (2014)

Baicalein and Baicalin Inhibit SARS-CoV-2 RNA-Dependent-RNA Polymerase
por: Zandi, Keivan, et al.
Publicado: (2021)

Studies on the Efficacy, Potential Cardiotoxicity and Monkey Pharmacokinetics of GLP-26 as a Potent Hepatitis B Virus Capsid Assembly Modulator
por: Hurwitz, Selwyn J., et al.
Publicado: (2021)

An ACE2-IgG4 Fc Fusion Protein Demonstrates Strong Binding to All Tested SARS-CoV-2 Variants and Reduced Lung Inflammation in Animal Models of SARS-CoV-2 and Influenza
por: Merigeon, Emmanuel Y., et al.
Publicado: (2022)

Assessment of the Abbott BinaxNOW SARS-CoV-2 rapid antigen test against viral variants of concern
por: Rao, Anuradha, et al.
Publicado: (2022)

Repurposing Nucleoside Analogs for Human Coronaviruses
por: Zandi, Keivan, et al.
Publicado: (2020)

Raltegravir Is a Potent Inhibitor of XMRV, a Virus Implicated in Prostate Cancer and Chronic Fatigue Syndrome
por: Singh, Ila R., et al.
Publicado: (2010)

Elimination of Aicardi–Goutières syndrome protein SAMHD1 activates cellular innate immunity and suppresses SARS-CoV-2 replication
por: Oo, Adrian, et al.
Publicado: (2022)

Synthesis of Nucleoside Phosphate and Phosphonate Prodrugs
por: Pradere, Ugo, et al.
Publicado: (2014)

Cross-sectional IgM and IgG profiles in SARS-CoV-2 infection
por: Ozturk, Tugba, et al.
Publicado: (2020)

Synthesis of Novel N(4)-Hydrocytidine Analogs as Potential Anti-SARS-CoV-2 Agents
por: Amblard, Franck, et al.
Publicado: (2022)

Single-Amplicon Multiplex Real-Time Reverse Transcription-PCR with Tiled Probes To Detect SARS-CoV-2 spike Mutations Associated with Variants of Concern
por: Babiker, Ahmed, et al.
Publicado: (2021)

Preclinical and clinical development of the anti-HIV, anti-HBV oxathiolane nucleoside analog emtricitabine
por: Painter, George R., et al.
Publicado: (2003)

Novel 1′-homo-N-2′-deoxy-α-nucleosides: synthesis, characterization and biological activity
por: Carnero, Alejandro, et al.
Publicado: (2020)

Deep mutational scanning identifies SARS-CoV-2 Nucleocapsid escape mutations of currently available rapid antigen tests
por: Frank, Filipp, et al.
Publicado: (2022)

Inactivation of SARS-CoV-2 and COVID-19 Patient Samples for Contemporary Immunology and Metabolomics Studies
por: Eddins, Devon J., et al.
Publicado: (2022)

Jak Inhibitors Modulate Production of Replication-Competent Zika Virus in Human Hofbauer, Trophoblasts, and Neuroblastoma cells
por: Gavegnano, Christina, et al.
Publicado: (2017)

Antibody Profiles According to Mild or Severe SARS-CoV-2 Infection, Atlanta, Georgia, USA, 2020
por: Hu, William T., et al.
Publicado: (2020)

Computational study of aggregation mechanism in human lysozyme[D67H]
por: Patel, Dharmeshkumar, et al.
Publicado: (2017)

Molnupiravir promotes SARS-CoV-2 mutagenesis via the RNA template
por: Gordon, Calvin J., et al.
Publicado: (2021)

S gene mutations of HBV in children with HBV-associated glomerulonephritis
por: Lu, Hongzhu, et al.
Publicado: (2012)

Inflammation and kidney involvement in human viral diseases caused by SARS-CoV-2, HIV, HCV and HBV
por: da Mata, Gustavo Ferreira, et al.
Publicado: (2021)

Monitoring the emergence of HBV resistance mutations by HBV-RNA pyrosequencing
por: Bottecchia, Marcelle, et al.
Publicado: (2015)

Encephalopathy and Encephalitis Associated with Cerebrospinal Fluid Cytokine Alterations and Coronavirus Disease, Atlanta, Georgia, USA, 2020
por: Benameur, Karima, et al.
Publicado: (2020)

Synthesis of 4′-Substituted Carbocyclic Uracil Derivatives and Their Monophosphate Prodrugs as Potential Antiviral Agents
por: Biteau, Nicolas G., et al.
Publicado: (2023)

Diastereoselective Synthesis of 2′-Dihalopyrimidine Ribonucleoside Inhibitors of Hepatitis C Virus Replication
por: Zhou, Longhu, et al.
Publicado: (2021)

Hepatitis B virus drug resistance mutations in HIV/HBV co-infected children in Windhoek, Namibia
por: Tamandjou Tchuem, Cynthia Raissa, et al.
Publicado: (2020)

Broad Range of Hepatitis B Virus (HBV) Patterns, Dual Circulation of Quasi-Subgenotype A3 and HBV/E and Heterogeneous HBV Mutations in HIV-Positive Patients in Gabon
por: Bivigou-Mboumba, Berthold, et al.
Publicado: (2016)

Prevalence of HBV infection in immunocompromised patients on ART nearly equals HBV mono infection in individuals not infected with HIV, Shimla Northern India
por: Garg, Aarti, et al.
Publicado: (2014)

SARS-CoV-2 in patients on antiviral HBV and HCV therapy in Spain
por: Lens, Sabela, et al.
Publicado: (2020)

Modeling SARS-CoV-2 and HBV co-dynamics with optimal control
por: Omame, Andrew, et al.
Publicado: (2023)

Discovery of a 2′-Fluoro,2′-Bromouridine Phosphoramidate Prodrug Exhibiting Anti-Yellow Fever Virus Activity in Culture and in Mice
por: LeCher, Julia C., et al.
Publicado: (2022)

Potential drug–drug interactions between antiretroviral therapy and treatment regimens for multi-drug resistant tuberculosis: Implications for HIV care of MDR-TB co-infected individuals
por: Mukonzo, Jackson, et al.
Publicado: (2019)

HBV genotypes and response to tenofovir disoproxil fumarate in HIV/HBV-coinfected persons
por: Bihl, Florian, et al.
Publicado: (2015)

Identification and computational analysis of mutations in SARS-CoV-2
por: Dey, Tathagata, et al.
Publicado: (2021)

HBV-RNA, Quantitative HBsAg, Levels of HBV in Peripheral Lymphocytes and HBV Mutation Profiles in Chronic Hepatitis B
por: Gozlan, Yael, et al.
Publicado: (2022)

Investigational drugs with dual activity against HBV and HIV (Review)
por: Sun, Shiyu, et al.
Publicado: (2021)

Computational guided approach for drug repurposing against SARS-CoV-2
por: Anand, Jigisha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_t1gid1n81jt54pn2vj9v5sgl2m